Bhausaheb Bagal

Clinical impact of panel-based error-corrected next generation sequencing versus flow cytometry to detect measurable residual disease (MRD) in acute myeloid leukemia (AML)

Nikhil Patkar, Chinmayee Kakirde, Anam Fatima Shaikh et al. · Leukemia · 2021 · 92 citations · Full text

Cytogenetic Profile in 7209 Indian Patients with <i>de novo</i> Acute Leukemia: A Single Centre Study from India

P. S. Kadam Amare, H. K. Jain, Sharayu Kabre et al. · Journal of Cancer Therapy · 2016 · 46 citations · Full text

Hematological Malignancy, Indian Patients, Molecular Diagnostic Techniques +15

Comparison of the efficacy and safety of Rituximab (Mabthera™) and its biosimilar (Reditux™) in diffuse large B-cell lymphoma patients treated with chemo-immunotherapy: A retrospective analysis

Partha Roy, Shiji John, Sadashiv Karankal et al. · Indian Journal of Medical and Paediatric Oncology · 2013 · 41 citations · Full text

Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy

Prashant Tembhare, Harshini Sriram, Twinkle Khanka et al. · Journal for ImmunoTherapy of Cancer · 2020 · 41 citations · Full text

COVID‐19 in cancer patients on active systemic therapy – Outcomes from LMIC scenario with an emphasis on need for active treatment

Anant Ramaswamy, Lingaraj Nayak, Nirmalya Roy Moulik et al. · Cancer Medicine · 2020 · 39 citations · Full text